Teicoplanin, a new glycopeptide antibiotic belonging to the same family as vancomycin, inhibits cell wall synthesis in Bacillus subtilis; the inhibition is accompanied by an intracellular accumulation of UDP-N-acetylmuramyl-pentapetide. A cell-free system from Bacillus stearothermophilus, capable of synthesizing peptidoglycan, is 50% inhibited by teicoplanin at 40 ,ug/ml and 100,% inhibited at 100 ,ug/ml; suppression of peptidoglycan synthesis is accompanied by parallel accumulation of the lipid intermediate. Teicoplanin binds to cell walls and forms a complex with N,N'-diacetyl-L-lysyl-D-alanyl-D-alanine. The association constant of this complex is 2.56 X 106 liters mol'1, calculated by spectrophotometric titration. The mechanism of action of teicoplanin is discussed in comparison with those of other inhibitors of cell wall biosynthesis, namely, vancomycin, ristocetin, and gardimycin.
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Teicoplanin is a new antibiotic chemically related to the group of glycopeptides which also includes vancomycin and ristocetin. It was isolated from the fermentation broth of Actinoplanes teichomyceticus nov. sp. (1, 12) and is endowed with outstanding bactericidal activity against grampositive pathogenic bacteria (11) . The antibiotic is a mixture of five components of very similar polarity (the T-A2 complex, formerly named teichomycin A2) and a more polar product (T-A3); the components of the T-A2 complex, accounting for 90 to 95% of the product, have the same molecular weight, ca. 1,900 (2) .
The main features distinguishing teicoplanin from the other glycopeptide antibiotics are the occurrence of glucosamine as the basic sugar and the presence of aliphatic acid residues. Teicoplanin is not active against the L form of Staphylococcus aureus derived from a susceptible strain (12) ; this is a primary indication that the antibiotic interacts with the bacterial cell wall. We made further investigations on the mechanism of action of teicoplanin, and we present data showing that: (i) teicoplanin inhibits peptidoglycan synthesis in intact cells and in "cell-free" systems; (ii) the inhibition by teicoplanin is reverted by cell wall; (iii) the antibiotic binds to walls of whole cells, rendering them resistant to the action of lysozyme; and (iv) a complex occurs between teicoplanin and the peptide N,N'-diacetyl-L-lysyl-D-alanyl-D-alanine (Ac2-L-lys-D-ala-D-ala), a synthetic analog of the pentapeptide precursor in the peptidoglycan synthesis.
Part of this work was presented at the 12th International Congress of Chemotherapy, July 1981, Florence, Italy.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacillus subtilis SB25 (His-Try-) and PB556/1 (Thy-), derived from strain W168, were grown in Difco Penassay medium (PY) or in Davis minimal medium (4) ,uCi/ml).
Incubation continued for a further 30 min, and then the antibiotic was added to a part of the culture. At intervals portions were transferred to cold 5% trichloroacetic acid, filtered on glass fiber disks (Whatman GF/C), washed in succession with 2% trichloroacetic acid, ethanol, and diethyl ether, and then dried and counted for radioactivity in a scintillation chamber with Instagel (Packard Instrument Co., Inc., Rockville, Md.) as scintillation fluid.
Measurements and identification of accumulated cell wall precursors. Nucleotide cell wall precursors were extracted as described by Garrett (5) and quantitated by the method of Reissig et al. (14) for the estimation of N-acetylamino sugars. To identify the precursor accumulated in the presence of teicoplanin, the following procedure was employed: as a growing culture of B. subtilis SB25 in PY broth reached the mid-exponential phase, 0.1 ,uCi of [14C]GlcNAc per ml was added to the medium and 1 min later 40 p.g of antibiotic per ml was added. After incubating a further 30 min, the cells were harvested and washed with standard saline citrate solution, and the nucleotides were extracted. Identification was accomplished by paper chromatography with reference nucleotides. Chromatograms were developed with either solvent A or B (see below). Reference nucleotides were localized under UV light, and the radioactivity was detected by a Packard chromatography scanner. Paper chromatography. Descending paper chromatography was performed on Whatman no. 1 paper strips (6 by 57 cm) for 24 h with the following solvents: solvent A, isobutyric acid-i M NH40H (5:3); and solvent B, 95% ethanol-1 M ammonium acetate (pH 7) (7.5:3).
Cell-free synthesis of peptidoglycan. The preparation of particulate enzyme from B. stearothermophilus and the peptidoglycan synthesis assay were done as described previously (17) .
Preparation of cell wails and membrane from B. stearothermophilus. Cells of B. stearothermophilus were harvested in the middle of the exponential growth, washed three times with standard saline citrate solution at 4°C, and frozen in liquid nitrogen; for the wall preparation, the frozen cell paste was ground in a blender with three times the wet weight of Superbrite (3 M Corp., Minn.), under ice-water cooling. After Superbrite was removed through a sintered glass funnel, the sediment between 6,000 x g (10 min) and 24,000 x g (20 min) was collected, washed twice with distilled water, suspended in 0.05 M potassium phosphate buffer (pH 6.8), and treated with 1 mg of pronase (Boehringer, Mannheim, Federal Republic of Germany) per ml at 37°C. The walls were centrifuged again at 24,000 x g (20 min), washed in succession with distilled water, 95% ethanol, absolute ethanol, and diethyl ether, and finally dried in vacuo.
For the membrane preparation, the cell paste was slowly thawed and gently resuspended in a buffer containing 50 mM Tris-hydrochloride (pH 7.8), 20 mM MgCl2, and 22% (wt/vol) sucrose. Lysozyme (Sigma Chemical Co., St. Louis, Mo.) at 0.4 mg/ml was added, and the suspension was incubated at 25°C until complete conversion into protoplast was observed by phase-contrast microscope. The incubation continued for a further 10 min, and then the protoplasts were collected by centrifugation at 3,000 x g (20 min). The pellet was gently resuspended in the above buffer, but without sucrose, to rupture the protoplasts.
DNase I (Worthington Diagnostics, Freehold, N.J.) and pancreatic RNase (Sigma) were added at a final concentration of 1 mg/ml, the suspension was incubated for 10 min at 25°C and centrifuged at 3,000 x g (10 min), and the pellet was discarded. The supernatant was then centrifuged for 30 min at 38,000 x g, and the membrane pellet was (Fig. 1) . In contrast, the syntheses of DNA, RNA, and protein, measured as uptake of thymidine, uracil, and phenylalanine, respectively, were practically unaffected for the first 10 min after exposure to teicoplanin.
Accumulation of cell wall precursors. Impairment of cell wall synthesis is usually accompanied with an intracellular accumulation of peptidoglycan precursors in the form of uridine nucleotide. Actually, the addition of teicoplanin to a growing culture of B. subtilis resulted in an evident accumulation of these precursors; the time course of the accumulation with different doses of antibiotic is reported in Fig. 2 .
The specific composition of the accumulated precursors depends on the step at which inhibition of cell wall synthesis occurs: when radioactively labeled N-acetylamino sugar nucleotides were extracted from teicoplanin-treated cells and cochromatographed with authentic samples of peptidoglycan precursors, a main peak of radioactivity was found with an Rf corresponding to that of UDP-MurNAc-pentapeptide in either the A or B solvent systems. This result indicates that the antibiotic does not inhibit the synthesis of the soluble precursors but interferes with a further step in the process of peptidoglycan formation.
Effect on cell-free synthesis of peptidoglycan. To obtain more detailed information about the specific target of teicoplanin, we tested the antibiotic on a cell-free system capable of synthesizing peptidoglycan from the precursors UDP-GIcNAc and UDP-MurNAc-pentapeptide through the formation of a lipid intermediate: a preparation from B. stearothermophilus was used, containing both cell wall and membrane fragments (15) .
The addition of teicoplanin to the cell-free system blocked the synthesis of peptidoglycan and at the same time stimulated the formation of the phospolipid intermediate (Fig. 3) . Antibiotic at a concentration of 40 ,ug/ml, corresponding to (13) first observed that the association between van- comycin and some peptidoglycan precursors or other suitable peptides resulted in a shift of the UV spectrum of the , so-,' / antibiotic; because of this phenomenon it was possible to utilize a relatively simple and reliable method based on the difference spectra to determine the parameters of the complex formation. In this work the interaction between tei-40 coplanin and the synthetic peptide Ac2-L-lys-D-ala-D-ala was I / studied by difference spectroscopy. Figure 6 shows a difference spectrum induced on teicoplanin by the peptide; a relative minimum at 283 nm and a sharp decrease at wavelengths shorter than 272 nm are relevant.
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The extent of the differential absorbance (AA) at a suitable wavelength can be used as a measure of the association o X , , , , , between the antibiotic and the peptide. In fact, to improve Teicoplanin firmly binds to bacterial walls, as revealed by the fact that the inhibition of peptidoglycan cell-free synthesis was completely reversed by the addition of appropriate amounts of the cell wall fragments in the assay mixture; a similar effect has been reported by Sinha and Neuhaus (16) for vancomycin.
However, the activity of the antibiotic gardimycin, an inhibitor of peptidoglycan polymerization (17) , was indifferent to cell wall concentration and was reversed by the addition of membranes. Thus, it appears to have a mode of action different from that of teicoplanin or vancomycin. As a consequence of teicoplanin binding to cell wall, cultures of M. luteus pretreated with the drug became more resistant to bacteriolysis by lysozyme, the same effect was observed with vancomycin and ristocetin. Vancomycin is already known to protect other bacterial species, such as S. aureus, Bacillus megatherium, and B. stearothermophilus, from the action of muralytic enzymes (6) .
The relationship between the ability to bind to cell wall and the bactericidal effect of these antibiotics is, however, still unclear. Chatterjee and Perkins (3) first demonstrated the formation of a complex between vancomycin and peptidoglycan precursors, namely, those terminating in D-alanyl-D-alanine. Then vancomycin and ristocetin were found to combine more generally with peptides having the two last amino acids of the carboxy terminus in the D-configuration (9, 10). Teicoplanin shows a high affinity for the peptide Ac2-L-Lys-D-Ala-D-Ala (KA = 2.56 x 106 liters mol-1); this value is in the same order of magnitude of those reported for the vancomycin complex (KA = 1.5 x 106 liters mol-1) (9) and the ristocetin complex (KA = 5.9 x 105 liters mol-1) (10) with the same peptide.
Although the specificity of the binding with peptides is not yet known, all the data presented here enable us to presume that the mechanism of action of teicoplanin is essentially similar to that of vancomycin and ristocetin. This mechanism is almost certainly related to the binding of the antibi- otic with the D-Ala-D-Ala termini of peptidoglycan or peptidoglycan precursors, but the exact step involved is still conversial.
The transfer of disaccharide-pentapeptide units from the lipid intermediate to a nascent peptidoglycan chain will be the most obvious target if the reaction sites are accessible to the drug. The inhibition of transpeptidase and carboxypeptidase reactions involving D-Ala-D-Ala termini and taking place outside of the cell membrane could also account for the bactericidal activity of these antibiotics, as suggested by Leyh-Bouille et al. (7) and Jordan and Reynolds (6) .
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